Published in J Physiol on January 01, 1981
Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics. J Physiol (1982) 0.92
Vasoactive intestinal polypeptide depolarizations in cat bladder parasympathetic ganglia. J Physiol (1986) 0.82
Changes in vasoactive intestinal polypeptide (VIP) levels in the rabbit oviduct at different hormonal stages. An immunohistochemical study. J Anat (1990) 0.75
Polypeptide with broad biological activity: isolation from small intestine. Science (1970) 4.14
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08
Transmission from vasoconstrictor and vasodilator nerves to single smooth muscle cells of the guinea-pig uterine artery. J Physiol (1969) 2.42
Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N Engl J Med (1975) 2.30
Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications. J Physiol (1978) 2.16
Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol (1979) 1.54
Dual vasoconstrictor and vasodilator innervation of the uterine arterial supply in the guinea pig. Circ Res (1968) 1.54
Effects on smooth muscle preparations of unidentified vasoactiv peptides from intestine and lung. Nature (1970) 1.51
Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med (1977) 1.47
Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion (1979) 1.36
Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat. Acta Physiol Scand (1979) 1.11
Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. Science (1977) 1.09
Effect of estrogens on the uterine blood flow of oophorectomized ewes. Am J Obstet Gynecol (1973) 1.05
Evidence for dual innervation of the human extrinsic uterine arteries. J Obstet Gynaecol Br Commonw (1969) 1.00
Assessment of the effects of vasoactive intestinal peptide (VIP) on blood flow through and salivation of the dog salivary gland in comparison with those of secretin, glucagon and acetylcholine. Br J Pharmacol (1979) 0.99
Mesenteric vasomotor effects of vasoactive intestinal polypeptide. Study on perfused isolated canine jejunal loops. Pflugers Arch (1974) 0.93
Occurrence of nerves containing vasoactive intestinal polypeptide immunoreactivity in the male genital tract. Life Sci (1977) 0.93
Effect of acetylcholine on the uterine vascular bed. Am J Obstet Gynecol (1967) 0.89
Effects of intestinal peptide mixture G2 and vasoactive intestinal peptide VIP on splanchnic circulation in the dog. Acta Chir Scand (1973) 0.87
Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium. Acta Physiol Scand (1979) 0.86
Peptidergic (vasoactive intestinal peptide) nerves in the genito-urinary tract. Neuroscience (1977) 0.86
Vasoactive intestinal polypeptide in tissues of the human female reproductive tract. Am J Obstet Gynecol (1979) 0.83
MEASUREMENT OF BLOOD-FLOW THROUGH UTERINE MUSCLE BY LOCAL INJECTION OF 133-XENON. Lancet (1964) 0.80
Effects of prostaglandins E1, E2, and F2alpha on uterine blood flow in nonpregnant sheep. Am J Physiol (1978) 0.80
Distribution of cholinergic vasomotor nerves to the parametrial arteries of some laboratory and domestic animals. J Reprod Fertil (1971) 0.77
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45
Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications. J Physiol (1978) 2.16
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond) (2007) 1.88
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract. J Physiol (1978) 1.59
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
PACAP and glutamate are co-stored in the retinohypothalamic tract. J Comp Neurol (2000) 1.49
Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med (1977) 1.47
Which factors are associated with trainees' confidence in performing obstetric and gynecological ultrasound examinations? Ultrasound Obstet Gynecol (2014) 1.45
The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas (2005) 1.44
Objective assessment of gynecologic laparoscopic skills using the LapSimGyn virtual reality simulator. Surg Endosc (2006) 1.44
Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci (1997) 1.40
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS. Acta Neurol Scand (1989) 1.39
Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion (1979) 1.36
Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the vagal nerves. Gastroenterology (1977) 1.30
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res (1987) 1.27
Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience (1989) 1.26
Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology (1983) 1.25
Spontaneous abortion: a prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants. Acta Obstet Gynecol Scand (2006) 1.24
Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta (2000) 1.23
Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res (1985) 1.22
Assessment of performance measures and learning curves for use of a virtual-reality ultrasound simulator in transvaginal ultrasound examination. Ultrasound Obstet Gynecol (2014) 1.22
Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut (1981) 1.22
Seasonal occurrence of Campylobacter spp. in surface waters and their correlation with standard indicator bacteria. Appl Environ Microbiol (1987) 1.21
Immunohistochemical evidence for a local VIP-ergic neuron system in the adrenal gland of the rat. Acta Physiol Scand (1981) 1.19
What can comparative studies of placental structure tell us?--A review. Placenta (2004) 1.17
Complete deletion of Apc results in severe polyposis in mice. Oncogene (2009) 1.16
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res (2001) 1.15
Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J Neurosci (2001) 1.14
Small rodents and other mammals associated with mountain meadows as reservoirs of Giardia spp. and Campylobacter spp. Appl Environ Microbiol (1987) 1.12
Substantial variability in postoperative treatment, and convalescence recommendations following vaginal repair. A nationwide questionnaire study. Acta Obstet Gynecol Scand (2001) 1.12
Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. Brain Res (1980) 1.12
Neuronal VIP in salivary glands: distribution and release. Acta Physiol Scand (1980) 1.11
Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide. Proc Natl Acad Sci U S A (1981) 1.11
Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol (2000) 1.09
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia (2008) 1.09
Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract. Science (1977) 1.09
VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res (1980) 1.08
Nasal swell-bodies and cyclic changes in the air passage of the rat and rabbit nose. J Anat (1971) 1.07
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
A rich VIP nerve supply is characteristic of sphincters. Nature (1979) 1.06
Objective assessment of surgical competence in gynaecological laparoscopy: development and validation of a procedure-specific rating scale. BJOG (2008) 1.06
Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience (1979) 1.05
Comparative placentation: some interesting modifications for histotrophic nutrition -- a review. Placenta (2006) 1.04
Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. Acta Med Scand (1980) 1.04
Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke (1996) 1.03
Distribution of vasoactive intestinal polypeptide (VIP) in the porcine central nervous system. J Neurochem (1978) 1.03
Migratory birds of central Washington as reservoirs of Campylobacter jejuni. Can J Microbiol (1988) 1.03
Vaginal physiology during menstruation. Ann Intern Med (1982) 1.03
Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity. Acta Physiol Scand (1979) 1.03
Vasoactive intestinal polypeptidergic nerves and Brunner's gland secretion in the rat. Gastroenterology (1981) 1.03
Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. Br Med J (Clin Res Ed) (1984) 1.03
Secretion pattern of secretin in man: regulation by gastric acid. Gut (1978) 1.02
Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol Scand (1981) 1.02
VIP innervation of the gallbladder. Gastroenterology (1977) 1.02
Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence. Cell Tissue Res (1986) 1.01
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. Acta Physiol Scand (1982) 1.00
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemost (2007) 1.00
Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept (1995) 0.99
Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion? Hum Reprod (2003) 0.99
Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Res (1978) 0.99
Peptide-containing nerve fibres in the gut wall in Crohn's disease. Gut (1983) 0.98
Radioimmunoassay of secretin in plasma. Scand J Clin Lab Invest (1977) 0.98
Neprilysin, obesity and the metabolic syndrome. Int J Obes (Lond) (2010) 0.96
Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand (2000) 0.96
Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer. Eur J Cancer Care (Engl) (2011) 0.96
Corelease of vasoactive intestinal polypeptide and peptide histidine isoleucine in relation to atropine-resistant vasodilation in cat submandibular salivary gland. Neurosci Lett (1984) 0.96
VIP as a mediator of hexamethonium-sensitive, atropine-resistant vasodilation in the cat tongue. Acta Physiol Scand (1982) 0.96
Expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the postnatal and adult rat cerebellar cortex. Neuroreport (1998) 0.96
Pancreatic response and plasma secretin concentration during infusion of low dose secretin in man. Scand J Gastroenterol (1978) 0.95
Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy. Br J Cancer (2004) 0.95
A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Diabetologia (2011) 0.95
Plasma beta-endorphin during clinical and experimental ischaemic pain. Scand J Clin Lab Invest (1987) 0.95
Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Am J Pathol (1976) 0.95
The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. Proc Natl Acad Sci U S A (1983) 0.94
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. I. VIP release. Acta Physiol Scand (1981) 0.94
Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience (1996) 0.94
Distribution, ontogeny and ultrastructure of the mammalian secretin cell. Cell Tissue Res (1977) 0.93
Light-dependent induction of cFos during subjective day and night in PACAP-containing ganglion cells of the retinohypothalamic tract. J Biol Rhythms (2001) 0.93
Peptidergic (VIP) nerves in the pancreas. Histochemistry (1978) 0.93
Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides (1988) 0.92
Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease. Brain Res (1979) 0.92
Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence. Brain Res (1995) 0.92
Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig. J Physiol (1981) 0.92
Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics. J Physiol (1982) 0.92
Human placentation from nidation to 5 weeks of gestation. Part I: What do we know about formative placental development following implantation? Placenta (2012) 0.92
Neuroglobin expression in the rat suprachiasmatic nucleus: colocalization, innervation, and response to light. J Comp Neurol (2010) 0.91
Axonal transport of neuropeptides in the cervical vagus nerve of the rat. J Neurochem (1980) 0.90
PACAP in the adrenal gland--relationship with choline acetyltransferase, enkephalin and chromaffin cells and effects of immunological sympathectomy. Neuroreport (1996) 0.90
Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCl, or ingestion of a meal. Eur J Clin Invest (1977) 0.90
Gastroenteropancreatic hormonal changes during exercise. Am J Physiol (1980) 0.90
Distribution and motor effect of VIP in female genital tract. Am J Physiol (1981) 0.90